What Is New in the Management of Childhood Tuberculosis in 2020?

Varinder Singh1, Ankit Parakh2

  • 1Department of Pediatrics, Lady Hardinge Medical College and Kalawati Saran Children's Hospital, New Delhi, India. Correspondence to: Dr Varinder Singh, Director-Professor, Department of Pediatrics, Lady Hardinge Medical College and Kalawati Saran Children's Hospital, New Delhi 110 001, India. 4vsingh@gmail.com.

Indian Pediatrics
|December 15, 2020
PubMed

Insights

India aims to eliminate tuberculosis (TB) by 2025, updating pediatric TB diagnosis and treatment strategies. New guidelines from the National Tuberculosis Elimination Program and Indian Academy of Pediatrics guide this pediatric TB management shift.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pediatrics

Background:

  • India targets tuberculosis (TB) elimination by 2025, aligning with but preceding the World Health Organization's global goal.
  • A significant shift in TB diagnostic and treatment approaches is underway across all age groups.
  • Pediatric TB management requires specific adaptations to meet national elimination targets.

Purpose of the Study:

  • To summarize critical updates in pediatric TB management.
  • To highlight changes informed by new guidelines from national health bodies.
  • To provide a resource for healthcare professionals managing childhood TB.

Main Methods:

  • Review of guidelines from the National Tuberculosis Elimination Program (NTEP).
  • Analysis of recommendations from the Indian Academy of Pediatrics (IAP).
  • Synthesis of changes specific to pediatric TB diagnosis and treatment.

Main Results:

  • The update details revised diagnostic criteria for pediatric TB.
  • It outlines updated treatment regimens tailored for children.
  • Changes reflect a comprehensive approach to pediatric TB elimination.

Conclusions:

  • The revised guidelines represent a strategic advancement in India's TB elimination efforts.
  • These updates are crucial for effective management of TB in children.
  • The national plan necessitates a focused approach to pediatric TB to achieve the 2025 goal.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
329
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
549
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
294
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
956
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
653
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K